Key Takeaways HIMS is set to report Q3 results with EPS estimated to be 9 cents and revenues of $583.7 million.HIMS' new hormonal health offerings and AI enhancements aim to expand reach and lift user engagement in Q3.HIMS continues to scale via women's health launches and global digital expansion, driving long-term growth.Hims & Hers Health, Inc. (HIMS) is scheduled to report third-quarter 2025 results on Nov. 3, after the closing bell.In the last reported quarter, the company’s earnings per share (EPS) of ...